| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |